In a murine model of Alzheimer’s disease, this molecule has also shown neuroprotection through enhancing the expression of genes correlated with neuroplasticity and reducing levels of NF-κB. This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.